Evolus, Inc. (EOLS)
4.60
-0.03
(-0.65%)
USD |
NASDAQ |
Apr 16, 09:33
Evolus Research and Development Expense (Annual) : 9.576M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Anika Therapeutics, Inc. | 25.77M |
| STAAR Surgical Co. | 39.28M |
| Sanara MedTech, Inc. | 5.072M |
| Quantum-Si, Inc. | 53.45M |
| Plus Therapeutics, Inc. | 8.379M |